Volker Fendrich

Philipps University of Marburg

Papers

2

Total Citations

97

H-Index

2

About

Volker Fendrich is a leading figure in endocrine and pancreatic surgery, with a focused expertise in neuroendocrine neoplasms (NENs) and hereditary tumor syndromes. His research has significantly advanced surgical decision-making for complex patient populations, particularly those with multiple endocrine neoplasia type 1 (MEN1). In a pivotal 2016 study, Fendrich demonstrated that minimally invasive pancreatic surgery offers comparable oncologic outcomes to open surgery for MEN1 patients with pancreatic neuroendocrine tumors (pNENs), a finding that has shaped modern treatment protocols and garnered over 50 citations. His work also pioneered the refinement of spleen-preserving distal pancreatectomy, showing that a robotic-assisted approach markedly improves vessel preservation rates compared to conventional techniques. This innovation, detailed in another highly cited 2016 paper, reduces morbidity and preserves organ function for patients with benign and borderline pancreatic tumors. With a career dedicated to translating surgical innovation into improved patient outcomes, Fendrich’s contributions have earned him international recognition, establishing him as a key authority in the minimally invasive management of pancreatic and endocrine diseases.

Research Focus

Key Achievements

2
H-Index
2
Papers
97
Total Citations
49
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1
53 citations · 2016
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Philipps University of Marburg

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago